Section Arrow
ACON.NASDAQ
- Aclarion Inc
Quotes are at least 15-min delayed:2026/07/23 14:47 EDT
Regular Hours
Last
 2.38
-0.17 (-6.67%)
Day High 
2.6489 
Prev. Close
2.55 
1-M High
3.17 
Volume 
35.54K 
Bid
2.38
Ask
2.46
Day Low
2.35 
Open
2.61 
1-M Low
2.46 
Market Cap 
6.28M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 2.67 
20-SMA 2.8 
50-SMA 3.05 
52-W High 12.03 
52-W Low 2.3401 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-5.63/--
Enterprise Value
6.28M
Balance Sheet
Book Value Per Share
7.98
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
45.72K
Operating Revenue Per Share
0.03
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ZCMDZhongchao Inc1.74-2.55-59.44%-- 
EVHEvolent Health4.8013-0.7687-13.80%-- 
TDOCTeladoc Health8.695-0.225-2.52%-- 
TEMTempus AI Inc.45.955-1.005-2.14%-- 
CERTCertara7.075+0.185+2.69%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietarysignal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.